This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
SIRT1 antibody
catalog :
VPA00294KT
quantity :
2 Westerns
price :
108 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot
product information
EntityType :
PrecisionAb™ Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00294KT
Description :
SIRT1 ANTIBODY WITH CONTROL LYSATE
Specificity :
SIRT1
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
CrossReactivities :
Mouse
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0006260, GO:0000122, GO:0000183, GO:0002039, GO:0003714, GO:0042393, GO:0006915, GO:0005637, GO:0005737, GO:0005677, GO:0005719, GO:0005720, GO:0005730, GO:0006281, GO:0006343, GO:0006344, GO:0006364, GO:0006642, GO:0007517, GO:0007569, GO:0008022, GO:0008270, GO:0042802, GO:0009267, GO:0042981, GO:0016564, GO:0016575, GO:0016605, GO:0018394, GO:0031937, GO:0032071, GO:0033158, GO:0033553, GO:0034339, GO:0034983, GO:0042127, GO:0043398, GO:0043425, GO:0043433, GO:0043518, GO:0044419, GO:0045599, GO:0045739, GO:0045768, GO:0046969, GO:0050872, GO:0051097, GO:0070403
GOTerms :
35S primary transcript processing, activation of anti-apoptosis, activation of chromatin silencing, activation of DNA repair, apoptosis regulator activity, apoptotic cell death, apoptotic program, apoptotic programmed cell death, carboxylate-terminal binding, carboxylate-terminus binding, carboxyl-terminal binding, carboxyl-terminus binding, carboxy-terminal binding, carboxy-terminus binding, cell ageing, chromatin silencing at ribosomal DNA, COOH-terminal binding, COOH-terminus binding, C-terminal binding, C-terminal end binding, down regulation of DNA damage response, signal transduction by p53 class mediator, down regulation of fat cell differentiation, down regulation of helicase activity, down regulation of transcription factor activity, down regulation of transcription from RNA polymerase II promoter, downregulation of DNA damage response, signal transduction by p53 class mediator, down-regulation of DNA damage response, signal transduction by p53 class mediator, downregulation of fat cell differentiation, down-regulation of fat cell differentiation, downregulation of helicase activity, down-regulation of helicase activity, downregulation of transcription factor activity, down-regulation of transcription factor activity, downregulation of transcription from RNA polymerase II promoter, down-regulation of transcription from RNA polymerase II promoter, endodeoxyribonuclease regulator, establishment of heterochromatic silencing, GO:0006365, GO:0008632, GO:0055133, heterochromatic silencing at rDNA, histone-specific chaperone activity, inhibition of DNA damage response, signal transduction by p53 class mediator, inhibition of fat cell differentiation, inhibition of helicase activity, inhibition of transcription factor activity, inhibition of transcription from RNA polymerase II promoter, inner envelope, interaction with another species, interspecies interaction, interspecies interaction with other organisms, isoform-specific homophilic binding, maintenance of heterochromatic silencing, NAD (oxidized) binding, NAD binding, ND10, negative regulation of adipocyte cell differentiation, negative regulation of adipocyte differentiation, negative regulation of p53 induced by DNA damage response, negative regulation of transcription from Pol II promoter, negative transcriptional regulator activity, nuclear dot, oxidized NAD binding, oxidized nicotinamide adenine dinucleotide binding, PML NB, PML nuclear body, positive regulation of heterochromatic silencing, programmed cell death by apoptosis, protein homopolymerization, protein lysine acetylation, rDNA chromatin silencing, regulation of protein import into cell nucleus, translocation, ribosomal DNA heterochromatin, signaling (initiator) caspase activity, stimulation of anti-apoptosis, stimulation of chromatin silencing, stimulation of DNA repair, transcription co-repressor activity, transcriptional repressor activity, triacylglycerol mobilization, type I programmed cell death, up regulation of anti-apoptosis, up regulation of chromatin silencing, up regulation of DNA repair, up-regulation of anti-apoptosis, upregulation of anti-apoptosis, upregulation of chromatin silencing, up-regulation of chromatin silencing, upregulation of DNA repair, up-regulation of DNA repair, white adipocyte cell differentiation, white adipocyte differentiation, zinc binding
UniprotAccessions :
Q96EB6
Gene :
SIRT1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=23411
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.